CT News and Research

RSS

ILROG guideline outlines treatment options for pediatric Hodgkin lymphoma patients

The International Lymphoma Radiation Oncology Group has issued a guideline that outlines the use of 3-D computed tomography (CT)-based radiation therapy planning and volumetric image guidance to more effectively treat pediatric Hodgkin lymphoma and to reduce the radiation dose to normal tissue, thus decreasing the risk of late side effects.

4 Mar 2015

IMRIS announces net loss of $6.8 million for fourth quarter 2014

IMRIS Inc. today reported financial results for the fourth quarter and full year ended December 31, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 fourth quarter was $6.8 million, or $0.13 per diluted share, on net revenues of $9.6 million.

4 Mar 2015

New insights into the use, outcomes of gluteoplasty and vaginal labiaplasty procedures

Two of the fastest-growing plastic surgery procedures are gluteoplasty or "butt augmentation," to improve the appearance of the buttocks; and labiaplasty to address cosmetic and functional concerns with the vagina.

3 Mar 2015

Experts review diagnostic approaches to treat obstructive coronary artery disease in women

Obstructive coronary artery disease (CAD) in women often presents with different types of symptoms than in men and can be challenging to diagnose due to a variety of factors. A national panel of experts convened to review the latest evidence regarding CAD in women, diagnostic approaches, and new types of tests and technologies.

3 Mar 2015

Milestones in the History of microCT

An interview with Alexander Sasov about the major milestones in the development of microCT over the past 15 years.

From Bruker BioSpin Group 2 Mar 2015

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

Mundipharma International Limited’s network of independent associated companies are launching Remsima® (infliximab) this month in Germany, Italy, UK, Netherlands, Belgium and Luxembourg following expiry of the relevant patents and Supplementary Protection Certificates, having secured distribution rights from Celltrion Healthcare Hungary Kft for Remsima in these markets.

1 Mar 2015

NYU Langone reminds people about importance of screening and preventing colorectal cancer

According to the U.S. Centers for Disease Control and Prevention, colorectal cancer is the second leading cause of cancer death in the United States. However, according to Mark Pochapin, MD, the Sholtz/Leeds professor of Gastroenterology and director of the Division of Gastroenterology at NYU Langone Medical Center : "With early screening and prevention, this is one cancer that is highly curable and often preventable."

28 Feb 2015

Researchers outline personalized surgical approach to ovarian cancer

A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor - a milestone strongly tied to improved survival.

28 Feb 2015

Majority of ACS NSQIP hospitals improve surgical outcomes over time

The majority of hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project improve surgical outcomes over time, and improvement continues with each year that hospitals participate in the program, according to a new study published online today in Annals of Surgery.

28 Feb 2015

Fat cell transplantation benefits systemic sclerosis patients with non-healing digital ulcers

Digital ulcers (DUs) are a frequent, painful, and quality of life altering complication for patients with systemic sclerosis (SSc), a connective tissue disease causing a progressive loss of small blood vessels and resulting changes in organs and tissues. DUs on the fingertips of SSc patients are slow to heal, if they heal at all, as many are unresponsive to any therapies.

26 Feb 2015

MR Solutions adds new 4.7T system to cryogen-free, preclinical MRI imaging family

A new addition to the cryogen-free, preclinical MRI imaging family, the 4.7T model, is now available to order. It joins the 3T and 7T systems for superior soft tissue contrast and molecular imaging research. This has been brought to the market by MR Solutions, the world’s largest independent developer and manufacturer of commercially available MRI technology.

From MR Solutions 26 Feb 2015

Smokers who quit early does not qualify for lung cancer screening, say Mayo Clinic researchers

A decline in smoking rates may mean that many people who could have benefited from early detection of lung cancer are dying because they don't qualify for low-dose CT scans, according to a group of Mayo Clinic researchers.

25 Feb 2015

PCORI funds five patient-centered comparative effectiveness research studies

The Patient-Centered Outcomes Research Institute Board of Governors today approved awards totaling more than $64 million to fund five large patient-centered comparative effectiveness research (CER) studies that will answer critical clinical questions about care for cancer, back pain, and stroke.

25 Feb 2015

Neighbors Health System forms strategic partnership with Siemens USA

Neighbors Health System, owner of Neighbors Emergency Center, announced today a strategic partnership with Siemens USA. Siemens will serve as the exclusive technology provider for imaging equipment in all new Neighbors Emergency Center facilities.

24 Feb 2015

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

According to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Acute Lymphoblastic Leukemia (ALL), the treatment approach to ALL is one of the most complex and intensive programs in cancer therapy.

24 Feb 2015

University of Tübingen, Mediso partner to develop whole body preclinical PET insert

University of Tübingen and Mediso Ltd announced today at the 4th Tübingen PET/MR Workshop to enter into a collaboration to develop a whole body preclinical PET insert based on silicon photomultiplier sensor technology. This system can be inserted into a high field (7T) preclinical MRI scanner to enable simultaneous PET/MR imaging.

23 Feb 2015

Two diagnostic tests can help identify children who require surgical treatment for appendicitis

Data from two standard diagnostic tests commonly obtained in children evaluated for abdominal pain--when combined--can improve the ability of emergency department physicians and pediatric surgeons to identify those patients who should be sent to the operating room for prompt removal of an inflamed appendix; those who may be admitted for observation; and those who may safely be discharged home, according to a new study published online as an "article in press" in the Journal of the American College of Surgeons.

20 Feb 2015

InflectraTM (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

Data have been presented today on the use of Hospira’s Inflectra (infliximab), the world’s first approved biosimilar monoclonal antibody (mAb), at the European Crohn’s and Colitis Organisation Inflammatory Bowel Diseases (ECCO-ibd) conference.

19 Feb 2015

Adeptus Health's net revenue increases 108.0% to $70.1 million in fourth quarter 2014

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., announced its results for the fourth quarter and full year ended December 31, 2014.

19 Feb 2015

Johns Hopkins study shows value follow-up PET/CT scans in patients with lung cancer

New research from Johns Hopkins School of Medicine reveals a high value of scans which could lead to future change of reimbursement policies for follow-up positron emission tomography/computed tomography (PET/CT) studies in lung cancer. The study, featured in the February 2015 issue of the Journal of Nuclear Medicine, establishes the value of fourth and subsequent follow-up PET/CT scans in clinical assessment and management change in patients with the disease.

19 Feb 2015

CT News and Research

ILROG guideline outlines treatment options for pediatric Hodgkin lymphoma patients

IMRIS announces net loss of $6.8 million for fourth quarter 2014

New insights into the use, outcomes of gluteoplasty and vaginal labiaplasty procedures

Experts review diagnostic approaches to treat obstructive coronary artery disease in women

Milestones in the History of microCT

Mundipharma launches Remsima® (infliximab), a new-generation value-based monoclonal antibody, in six European markets

NYU Langone reminds people about importance of screening and preventing colorectal cancer

Researchers outline personalized surgical approach to ovarian cancer

Majority of ACS NSQIP hospitals improve surgical outcomes over time

Fat cell transplantation benefits systemic sclerosis patients with non-healing digital ulcers

MR Solutions adds new 4.7T system to cryogen-free, preclinical MRI imaging family

Smokers who quit early does not qualify for lung cancer screening, say Mayo Clinic researchers

PCORI funds five patient-centered comparative effectiveness research studies

Neighbors Health System forms strategic partnership with Siemens USA

New NCCN Guidelines for treating Acute Lymphoblastic Leukemia

University of Tübingen, Mediso partner to develop whole body preclinical PET insert

Two diagnostic tests can help identify children who require surgical treatment for appendicitis

InflectraTM (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease

Adeptus Health's net revenue increases 108.0% to $70.1 million in fourth quarter 2014

Johns Hopkins study shows value follow-up PET/CT scans in patients with lung cancer

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News